The role of antifungal treatment in hematology
Open Access
- 1 March 2012
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 97 (3), 325-327
- https://doi.org/10.3324/haematol.2012.061952
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?British Journal of Haematology, 2011
- Optimizing management of invasive mould diseasesJournal of Antimicrobial Chemotherapy, 2010
- An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortalityBone Marrow Transplantation, 2009
- Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patientsJournal of Clinical Pathology, 2008
- Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysisEuropean Journal Of Cancer, 2008
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint.Journal of the National Comprehensive Cancer Network, 2008
- Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with NeutropeniaNew England Journal of Medicine, 2007
- Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility StudyClinical Infectious Diseases, 2005
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992